BX Swiss TOP 30 CHF
1.240,77
PKT
+4,75
PKT
+0,38
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.03.20 | Givaudan Underperform | Bernstein Research | |
| 27.03.20 | Nestlé overweight | JP Morgan Chase & Co. | |
| 27.03.20 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 27.03.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 27.03.20 | Swiss Re Sector Perform | RBC Capital Markets | |
| 26.03.20 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 26.03.20 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 26.03.20 | UBS Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.03.20 | UBS buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.03.20 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.03.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 25.03.20 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.03.20 | Nestlé buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.03.20 | Roche buy | UBS AG | |
| 24.03.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.03.20 | Nestlé buy | UBS AG | |
| 23.03.20 | Zurich Insurance buy | UBS AG | |
| 23.03.20 | Nestlé Underperform | RBC Capital Markets | |
| 23.03.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 20.03.20 | Novartis Hold | Deutsche Bank AG | |
| 20.03.20 | Roche buy | Deutsche Bank AG | |
| 19.03.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 19.03.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 19.03.20 | UBS Sector Perform | RBC Capital Markets | |
| 19.03.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 18.03.20 | Givaudan Underweight | Morgan Stanley | |
| 18.03.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 18.03.20 | Nestlé Hold | Jefferies & Company Inc. | |
| 17.03.20 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 17.03.20 | Nestlé overweight | JP Morgan Chase & Co. | |
| 17.03.20 | Roche overweight | Barclays Capital | |
| 17.03.20 | Novartis Underweight | Barclays Capital | |
| 17.03.20 | UBS Sector Perform | RBC Capital Markets | |
| 17.03.20 | UBS Sector Perform | RBC Capital Markets | |
| 17.03.20 | Nestlé overweight | Barclays Capital | |
| 13.03.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.03.20 | Givaudan Underperform | Bernstein Research | |
| 12.03.20 | UBS buy | UBS AG | |
| 11.03.20 | Novartis Equal-Weight | Morgan Stanley | |
| 11.03.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. |